EMA Publish List of references supporting the assessment of Oenothera biennis L.; Oenothera lamarckiana L., oleum
Full Text Here
The Agency acknowledges that copies of the underlying works used to produce this monograph were provided for research only with exclusion of any commercial purpose.
Abou El-Ela SH, Prasse KW, Carroll R, et al. Effects of dietary primrose oil on mammary tumorigenesis induced by 7,12-dimethylbenz(a)anthracene. Lipids 1987; 22(12): 1041-1044
Abou El-Ela SH, Prasse KW, Carroll R, et al. Eicosanoid synthesis in 7,12-dimethylbenz(a)anthracene-induced mammary carcinomas in sprague-dawley rats fed primrose oil, menhaden oil or corn oil diet. Lipids 1988; 23(10): 948-954
Aman MG, Mitchell EA, Turbott SH. The effects of essential fatty acid supplementation by Efamol in hyperactive children. J Abnorm Child Psychol 1987; 15(1): 75-90
Al-Shabanah OA. Effect of evening primrose oil on gastric ulceration and secretion induced by various ulcerogenic and necrotizing agents in rats. Food Chem Toxicol 1997; 35(8): 769-775
Anonymous. Surgical research society abstracts. Br J Surg 1981; 68: 801-824
Anstey A, Quigley M, Wilkinson JD. Topical evening primrose oil as treatment for atopic eczema. J Dermatol Treat 1990; 1: 199-201
Bamford JTM, Gibson RW, Renier CM. Atopic eczema unresponsive to evening primrose oil (linoleic and -linolenic acids). J Am Acad Dermatol 1985; 13(6): 959-965
Barnes J, Anderson LA, Phillipson JD. Herbal Medicines. Pharmaceutical Press, London 2007, 251-255
Bédard M. Evening primrose oil – still promising, but unproven. Can Pharm J 2003; 136(10): 41-42
Belch JJF, Shaw B, O’Dowd A, et al. Evening primrose oil (Efamol) as a treatment for cold-induced vasospasm (Raynauds phenomenon). Prog Lipid Res 1986; 25: 335-340
For Assistance with Regulating Herbal Products in the UK, EU and USA Click Here
Damien Bové is THE Drug Development and Regulatory Consultant (pharmaceutical or biotechnology), I work with my clients to define a drug development target, define a drug development strategy, define a regulatory strategy or define a commercial strategy. Our clients are generally raising funds or looking to license out their technology and we help them achieve it. If you want to know more don’t hesitate to get in touch.
Avoid Expensive Mistakes, Keep On Top of New and Changing Regulations for Free!
Sign up for the most value add free newsource you can get for free. We spend a huge amount of time and effort monitoring the main drug / device regulators websites for changes in the regulatory environment, and capture between 20 and 40 new regulations, rules and initiatives each month, and summaries them in a fantastic FREE monthly Regulatory and Market Round Up. You can Un-Subscribe at any time and we don not share your details with anybody. You can’t afford to miss out on this service. Just fill in the form below.
Fill Out the Short Form Below…
“Please note that the pages on this website are designed to provide you with general information only. We make no warranties, representations or undertakings about any of its content. This includes the completeness, accuracy and fitness for any particular purpose, or the content of any third party site referred to or accessed through it. You are personally responsible for ensuring that the information is correct and we will not be held liable or accountable for any mistakes that occur.”